全文获取类型
收费全文 | 1044428篇 |
免费 | 123051篇 |
国内免费 | 691篇 |
出版年
2016年 | 10900篇 |
2015年 | 16579篇 |
2014年 | 19230篇 |
2013年 | 27155篇 |
2012年 | 30603篇 |
2011年 | 30758篇 |
2010年 | 20814篇 |
2009年 | 19625篇 |
2008年 | 27889篇 |
2007年 | 28926篇 |
2006年 | 27178篇 |
2005年 | 26303篇 |
2004年 | 26072篇 |
2003年 | 25142篇 |
2002年 | 24524篇 |
2001年 | 44864篇 |
2000年 | 45775篇 |
1999年 | 36520篇 |
1998年 | 13537篇 |
1997年 | 14172篇 |
1996年 | 13408篇 |
1995年 | 13132篇 |
1994年 | 12980篇 |
1993年 | 12835篇 |
1992年 | 30932篇 |
1991年 | 29972篇 |
1990年 | 29395篇 |
1989年 | 28617篇 |
1988年 | 26594篇 |
1987年 | 25857篇 |
1986年 | 24086篇 |
1985年 | 24160篇 |
1984年 | 20267篇 |
1983年 | 17637篇 |
1982年 | 14099篇 |
1981年 | 12785篇 |
1980年 | 11969篇 |
1979年 | 19667篇 |
1978年 | 15814篇 |
1977年 | 14453篇 |
1976年 | 13665篇 |
1975年 | 14958篇 |
1974年 | 16170篇 |
1973年 | 15990篇 |
1972年 | 14533篇 |
1971年 | 13342篇 |
1970年 | 11516篇 |
1969年 | 11070篇 |
1968年 | 10024篇 |
1967年 | 8841篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Clémence L. Gamblin émilie J.-L. Hardy Fran?ois J.-M. Chartier Nicolas Bisson Patrick Laprise 《The Journal of cell biology》2014,204(4):487-495
During epithelial cell polarization, Yurt (Yrt) is initially confined to the lateral membrane and supports the stability of this membrane domain by repressing the Crumbs-containing apical machinery. At late stages of embryogenesis, the apical recruitment of Yrt restricts the size of the apical membrane. However, the molecular basis sustaining the spatiotemporal dynamics of Yrt remains undefined. In this paper, we report that atypical protein kinase C (aPKC) phosphorylates Yrt to prevent its premature apical localization. A nonphosphorylatable version of Yrt dominantly dismantles the apical domain, showing that its aPKC-mediated exclusion is crucial for epithelial cell polarity. In return, Yrt counteracts aPKC functions to prevent apicalization of the plasma membrane. The ability of Yrt to bind and restrain aPKC signaling is central for its role in polarity, as removal of the aPKC binding site neutralizes Yrt activity. Thus, Yrt and aPKC are involved in a reciprocal antagonistic regulatory loop that contributes to segregation of distinct and mutually exclusive membrane domains in epithelial cells. 相似文献
2.
Andrea Dichlberger Stefanie Schlager Katariina Maaninka Wolfgang J. Schneider Petri T. Kovanen 《Journal of lipid research》2014,55(12):2471-2478
Human mast cells (MCs) contain TG-rich cytoplasmic lipid droplets (LDs) with high arachidonic acid (AA) content. Here, we investigated the functional role of adipose TG lipase (ATGL) in TG hydrolysis and the ensuing release of AA as substrate for eicosanoid generation by activated human primary MCs in culture. Silencing of ATGL in MCs by siRNAs induced the accumulation of neutral lipids in LDs. IgE-dependent activation of MCs triggered the secretion of the two major eicosanoids, prostaglandin D2 (PGD2) and leukotriene C4 (LTC4). The immediate release of PGD2 from the activated MCs was solely dependent on cyclooxygenase (COX) 1, while during the delayed phase of lipid mediator production, the inducible COX-2 also contributed to its release. Importantly, when ATGL-silenced MCs were activated, the secretion of both PGD2 and LTC4 was significantly reduced. Interestingly, the inhibitory effect on the release of LTC4 was even more pronounced in ATGL-silenced MCs than in cytosolic phospholipase A2-silenced MCs. These data show that ATGL hydrolyzes AA-containing TGs present in human MC LDs and define ATGL as a novel regulator of the substrate availability of AA for eicosanoid generation upon MC activation. 相似文献
3.
4.
Laura C. Burzynski Melanie Humphry Martin R. Bennett Murray C. H. Clarke 《The Journal of biological chemistry》2015,290(41):25188-25196
Inflammation is a key instigator of the immune responses that drive atherosclerosis and allograft rejection. IL-1α, a powerful cytokine that activates both innate and adaptive immunity, induces vessel inflammation after release from necrotic vascular smooth muscle cells (VSMCs). Similarly, IL-1α released from endothelial cells (ECs) damaged during transplant drives allograft rejection. However, IL-1α requires cleavage for full cytokine activity, and what controls cleavage in necrotic ECs is currently unknown. We find that ECs have very low levels of IL-1α activity upon necrosis. However, TNFα or IL-1 induces significant levels of active IL-1α in EC necrotic lysates without alteration in protein levels. Increased activity requires cleavage of IL-1α by calpain to the more active mature form. Immunofluorescence and proximity ligation assays show that IL-1α associates with interleukin-1 receptor-2, and this association is decreased by TNFα or IL-1 and requires caspase activity. Thus, TNFα or IL-1 treatment of ECs leads to caspase proteolytic activity that cleaves interleukin-1 receptor-2, allowing IL-1α dissociation and subsequent processing by calpain. Importantly, ECs could be primed by IL-1α from adjacent damaged VSMCs, and necrotic ECs could activate neighboring normal ECs and VSMCs, causing them to release inflammatory cytokines and up-regulate adhesion molecules, thus amplifying inflammation. These data unravel the molecular mechanisms and interplay between damaged ECs and VSMCs that lead to activation of IL-1α and, thus, initiation of adaptive responses that cause graft rejection. 相似文献
5.
More than 50 hereditary lysosomal storage disorders (LSDs) are currently described. Most of these disorders are due to a deficiency of certain hydrolases/glycosidases and subsequent accumulation of nonhydrolyzable carbohydrate-containing compounds in lysosomes. Such accumulation causing hypertrophy of the lysosomal compartment is a characteristic feature of affected cells in LSDs. The investigation of biochemical and cellular parameters is of particular interest for understanding “life” of lysosomes in the normal state and in LSDs. This review highlights the wide spectrum of biochemical and morphological changes during developing LSDs that are extremely critical for many metabolic processes inside the various cells and tissues of affected persons. The data presented will help establish new complex strategies for metabolic correction of LSDs. 相似文献
6.
7.
8.
9.
10.